Formulation including doxycycline hyclate and method for administering the same
US12005068B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Inventor
Key dates
| Filing date | Sep 16, 2020 |
| Grant date | Jun 11, 2024 |
| Priority date | — |
| Expiry date | Mar 26, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A topical formulation for transdermal delivery of sub-acute does of doxycycline hyclate to treat pain and inflammation may include: a base suspension; and doxycycline hyclate. The doxycycline hyclate is mixed with the base suspension in a proportion such that the formulation lacks any antibiotic effect and the concentration of doxycycline hyclate is between 200 and 600 mg/g inclusive. A method of applying the formulation is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.